These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10999244)

  • 41. Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study.
    Kim JM; Kim SW; Stewart R; Kim SY; Yoon JS; Jung SW; Lee MS; Yim HW; Jun TY
    Hum Psychopharmacol; 2011 Jan; 26(1):41-50. PubMed ID: 21344501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Maudsley Staging Method for treatment-resistant depression: prediction of longer-term outcome and persistence of symptoms.
    Fekadu A; Wooderson SC; Markopoulou K; Cleare AJ
    J Clin Psychiatry; 2009 Jul; 70(7):952-7. PubMed ID: 19457299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up.
    Mueller TI; Leon AC; Keller MB; Solomon DA; Endicott J; Coryell W; Warshaw M; Maser JD
    Am J Psychiatry; 1999 Jul; 156(7):1000-6. PubMed ID: 10401442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anxious versus non-anxious depression: difference in treatment outcome.
    Domschke K; Deckert J; Arolt V; Baune BT
    J Psychopharmacol; 2010 Apr; 24(4):621-2. PubMed ID: 18838496
    [No Abstract]   [Full Text] [Related]  

  • 45. A pilot study of acupuncture augmentation therapy in antidepressant partial and non-responders with major depressive disorder.
    Yeung AS; Ameral VE; Chuzi SE; Fava M; Mischoulon D
    J Affect Disord; 2011 Apr; 130(1-2):285-9. PubMed ID: 20692042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical predictors of response and remission in inpatients with depressive syndromes.
    Riedel M; Möller HJ; Obermeier M; Adli M; Bauer M; Kronmüller K; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Schennach-Wolff R; Henkel V; Seemüller F
    J Affect Disord; 2011 Sep; 133(1-2):137-49. PubMed ID: 21555156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tachyphylaxis in unipolar major depressive disorder.
    Solomon DA; Leon AC; Mueller TI; Coryell W; Teres JJ; Posternak MA; Judd LL; Endicott J; Keller MB
    J Clin Psychiatry; 2005 Mar; 66(3):283-90. PubMed ID: 15766292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical criteria in evaluating recovery from depression. Methodologic aspects].
    Ansseau M
    Encephale; 1993 Aug; 19 Spec No 3():441-4. PubMed ID: 8299542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors associated with recurrent depression: a prospective study in family practice.
    Suija K; Aluoja A; Kalda R; Maaroos HI
    Fam Pract; 2011 Feb; 28(1):22-8. PubMed ID: 20864591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The naturalistic course of unipolar major depression in the absence of somatic therapy.
    Posternak MA; Solomon DA; Leon AC; Mueller TI; Shea MT; Endicott J; Keller MB
    J Nerv Ment Dis; 2006 May; 194(5):324-9. PubMed ID: 16699380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maintenance pharmacotherapy for recurrent major depressive disorder in primary care: A 5-year follow-up study.
    Riihimäki K; Vuorilehto M; Isometsä E
    Eur Psychiatry; 2017 Mar; 41():111-114. PubMed ID: 28135593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Explaining functional outcomes in depression treatment: a multilevel modelling approach.
    Gadelrab HF; Cabello M; Vieta E; Valle J; Leonardi M; Chatterji S; Ayuso-Mateos JL
    Disabil Rehabil; 2010; 32 Suppl 1():S105-15. PubMed ID: 20874448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Duration of subsequent episodes and periods of recovery in recurrent major depression.
    de Jonge P; Conradi HJ; Kaptein KI; Bockting CL; Korf J; Ormel J
    J Affect Disord; 2010 Sep; 125(1-3):141-5. PubMed ID: 20074810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Executive function differences between first episode and recurrent major depression patients].
    Karabekiroğlu A; Topçuoğlu V; Gimzal Gönentür A; Karabekiroğlu K
    Turk Psikiyatri Derg; 2010; 21(4):280-8. PubMed ID: 21125503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adequacy of antidepressant treatment in Spanish primary care: a naturalistic six-month follow-up study.
    Pinto-Meza A; Fernandez A; Serrano-Blanco A; Haro JM
    Psychiatr Serv; 2008 Jan; 59(1):78-83. PubMed ID: 18182543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum brain-derived neurotrophic factor levels at 6 months after remission are not associated with subsequent depressive episodes.
    Yoshimura R; Hori H; Sugita-Ikenouchi A; Umene-Nakano W; Katsuki A; Nakamura J
    J Clin Psychopharmacol; 2013 Feb; 33(1):142-3. PubMed ID: 23288242
    [No Abstract]   [Full Text] [Related]  

  • 57. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.
    Judd LL; Akiskal HS; Maser JD; Zeller PJ; Endicott J; Coryell W; Paulus MP; Kunovac JL; Leon AC; Mueller TI; Rice JA; Keller MB
    J Affect Disord; 1998 Sep; 50(2-3):97-108. PubMed ID: 9858069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical features of major depressive disorders treated in secondary health care facilities in Chile].
    Salvo L; Saldivia S; Parra C; Rodríguez R; Cifuentes M; Acevedo P; Díaz M; Ormazabal M; Guerra I; Navarrete N; Bravo V; Castro A
    Rev Med Chil; 2017 Mar; 145(3):335-343. PubMed ID: 28548190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?
    Judd LL; Paulus MJ; Schettler PJ; Akiskal HS; Endicott J; Leon AC; Maser JD; Mueller T; Solomon DA; Keller MB
    Am J Psychiatry; 2000 Sep; 157(9):1501-4. PubMed ID: 10964869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients.
    Deflesselle E; Verstuyft C; Petit AC; Hardy P; David DJ; Falissard B; Fève B; Rigal L; Becquemont L; Corruble E; Colle R
    Pharmacogenomics; 2017 Mar; 18(4):349-357. PubMed ID: 28244805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.